CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway

被引:0
作者
Zhongwei Zhao
Jingjing Song
Bufu Tang
Shiji Fang
Dengke Zhang
Liyun Zheng
Fazong Wu
Yang Gao
Chunmiao Chen
Xianghua Hu
Qiaoyou Weng
Yang Yang
Jianfei Tu
Jiansong Ji
机构
[1] The Fifth Affiliated Hospital of Wenzhou Medical University /Affiliated Lishui Hospital of Zhejiang University/ Clinical College of The Affiliated Central Hospital of Lishui University,Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention
来源
Journal of Experimental & Clinical Cancer Research | / 39卷
关键词
Hepatocellular carcinoma; Circular RNA; JAK2/STAT3; DNMT3a;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
    Zhao, Zhongwei
    Song, Jingjing
    Tang, Bufu
    Fang, Shiji
    Zhang, Dengke
    Zheng, Liyun
    Wu, Fazong
    Gao, Yang
    Chen, Chunmiao
    Hu, Xianghua
    Weng, Qiaoyou
    Yang, Yang
    Tu, Jianfei
    Ji, Jiansong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [2] LCN2 Promotes Proliferation and Glycolysis by Activating the JAK2/STAT3 Signaling Pathway in Hepatocellular Carcinoma
    Baojun Han
    Zhiming An
    Teng Gong
    Yu Pu
    Ke Liu
    Applied Biochemistry and Biotechnology, 2024, 196 : 717 - 728
  • [3] LCN2 Promotes Proliferation and Glycolysis by Activating the JAK2/STAT3 Signaling Pathway in Hepatocellular Carcinoma
    Han, Baojun
    An, Zhiming
    Gong, Teng
    Pu, Yu
    Liu, Ke
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (02) : 717 - 728
  • [4] Hsa circ 0013561 promotes progression of nasopharyngeal carcinoma by activating JAK2/STAT3 signaling pathway
    Kaisai, Tian
    Mantang, Zheng
    Tailei, Yuan
    Liying, Zheng
    Xiaoping, Chen
    Mingming, Jin
    Yi, Zhang
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2024, 90 (01)
  • [5] LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway
    Li, S. -J.
    Sui, M. -H.
    Sun, Z. -X.
    Zhang, W. -W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (03) : 1038 - 1046
  • [6] Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375
    Li, Liheng
    Xiao, Chengjiang
    He, Ke
    Xiang, Guoan
    IUBMB LIFE, 2021, 73 (09) : 1153 - 1165
  • [7] Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
    Hu, Xue
    Jiao, Fangzhou
    Zhang, Lan
    Jiang, Yingan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway
    Deng, Hao
    Gong, Xiaobo
    Ji, Guanghai
    Li, Chenglong
    Cheng, Shaoping
    MOLECULAR AND CELLULAR PROBES, 2023, 72
  • [9] YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway
    Zheng, Hongmei
    Tang, Yaoxiang
    Zang, Hongjing
    Luo, Jiadi
    Zhou, Hanqiong
    Zou, Ying
    Peng, Jinwu
    Fan, Songqing
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [10] Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling
    Yi, Feng-Tao
    Lu, Qi-Ping
    ONCOLOGY LETTERS, 2017, 14 (06) : 7571 - 7576